David-Alexandre C. Gros
Chief Executive Officer, Director · Eledon Pharmaceuticals, Inc.
- 2024
- Aug 4, 2026
- 2
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as David-Alexandre C. Gros. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $17.35M in ELDN purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David-Alexandre C. Gros?
David-Alexandre C. Gros is a corporate insider, tracked as Chief Executive Officer, Director of Eledon Pharmaceuticals, Inc. (ELDN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David-Alexandre C. Gros submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.